P53 expression and p21 expression are mutually exclusive in esophageal squamous cell carcinoma

Oncology Reports

Volumn 11, Issue 1, 2004, Pages 57-63

  Hamada, Madoka ^a   Naomoto, Yoshio ^a   Shirakawa, Yasuhiro ^a   Yamatsuji, Tomoki ^a   Noma, Kazuhiro ^a   Motoki, Takayuki ^a   Nobuhisa, Tetsuji ^a   Okawa, Takaomi ^a   Haisa, Minoru ^a   Gunduz, Mehmet ^a   Matsuoka, Junji ^a   Tanaka, Noriaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Esophagus; P21; P53; Squamous cell carcinoma

Indexed keywords

PROTEIN P21; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CANCER STAGING; COMPARATIVE STUDY; ESOPHAGUS TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; NICK END LABELING; PATHOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEIN P21(RAS); RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3543083461     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.1.57     Document Type: Article

References (28)

1. Japanese Cancer Association: Cancer treatment and survival. Monogr Cancer Res 43: 39-46, 1995
2. Kerr JF, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
3. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810, 1994. (Pubitemid 24359290)
4. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, et al: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994. (Pubitemid 24108052)
5. Waldman T, Kinzler KW and Vogelstein B: p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55:5187-5190, 1995.
6. Waga S, Hannon GJ, Beach D and Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578, 1994. (Pubitemid 24192528)
7. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB and Roth JA: Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 54: 2287-2291, 1994. (Pubitemid 24138709)
8. Barnes DM, Dublin EA, Fisher CJ, Levison DA and Millis RR: Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Hum Pathol 24: 469-476, 1993. (Pubitemid 23145798)
9. Ito K, Watanabe K, Nasim S, Sasano H, Sato S, Yajima A, Silverberg SG and Garrett CT: Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res 54: 4667-4670, 1994. (Pubitemid 24276491)
10. Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH, et al: Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84: 845-855, 1992.
11. Wang DY, Xiang YY, Tanaka M, Li XR, Li JL, Shen Q, Sugimura H and Kino I: High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer 74: 3089-3096, 1994. (Pubitemid 24375063)
12. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY and Yang CS: p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 54: 4342-4346, 1994.
13. Hamada M, Naomoto Y, Fujiwara T, Kamikawa Y and Tanaka N: Suppressed apoptotic induction in esophageal squamous cell carcinomas expressing extensive p53 protein. Jpn J Clin Oncol 26: 398-404, 1996. (Pubitemid 126471797)
14. Sasano H, Goukon Y, Nishihira T and Nagura H: In situ hybridization and immunohistochemistry of p53 tumor suppressor gene in human esophageal carcinoma. Am J Pathol 141: 545-550, 1992.
15. Bardeesy N, Beckwith JB and Pelletier J: Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res 55: 215-219, 1995.
16. Yang ZY, Perkins ND, Ohno T, Nabel EG and Nabel GJ: The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med 1: 1052-1056, 1995.
17. Qun W, Kirschmeier P, Hockenberry T, Yang TY, Brassard DL, Wang L, McClanahan T, Black S, Rizzi G, Musco ML, Mirza A and Liu S: Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells. J Biol Chem 277: 36329-36337, 2002
18. Shirakawa Y, Naomoto Y, Kimura M, Kawashima R, Yamatsuji T, Tamaki T, Hamada M, Haisa M and Tanaka N: Topological analysis of p21WAF1/CIP1 expression in esophageal squamous dysplasia. Clin Cancer Res 6: 541-550, 2000. (Pubitemid 30111477)
19. Shin RW, Iwaki T, Kitamoto T and Tateishi J: Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab Invest 64: 693-702, 1991.
20. Gavrieli Y, Sherman Y and Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
21. Miyashita T and Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299, 1995.
22. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE and Givol D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391-3395, 1994. (Pubitemid 24225956)
23. El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, et al: Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55: 2910-2919, 1995.
24. Shin DM, Kim J, Ro JY, Hittelman J, Roth JA, Hong WK and Hittelman WN: Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis.
25. Wang LD, Hong JY, Qiu SL, Gao H and Yang CS: Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res 53: 1783-1787, 1993. (Pubitemid 23127103)
26. Stinchcomb DT: Constraining the cell cycle: regulating cell division and differentiation by gene therapy. Nat Med 1: 1004-1006, 1995.
27. Rusch V, Klimstra D, Venkatraman E, Oliver J, Martini N, Gralla R, Kris M and Dmitrovsky E: Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer. Cancer Res 55: 5038-5042, 1995.
28. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travali S, Deisseroth AB and Mercer WE: p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 55: 668-674, 1995.